Browse > Article
http://dx.doi.org/10.7841/ksbbj.2011.26.1.078

Effect of Silybin on Body Weight and Glucose Tolerance in High-fat-diet Induced Obese Mice  

Hur, Haeng-Jeon (Biogeron Research Group, Korea Food Research Institute)
Hwang, Jin-Taek (Biogeron Research Group, Korea Food Research Institute)
Publication Information
KSBB Journal / v.26, no.1, 2011 , pp. 78-82 More about this Journal
Abstract
In this study, we investigated the effects of silybin on body weight and glucose tolerance in mice fed high fat diet mice. We found that body weight, plasma TG contents, fat size, glycerol, 3-hydroxybutyrate and total cholesterol were significantly decreased in silybin (500 mg/kg) supplemented groups compared to high fat diet group. Whereas, total food intake was not changed between high fat diet group and high fat diet plus silybin group. Futhermore, supplement of high fat elevated the glucose intolerance and was improved in silybin supplement group. Finally, we examined the effect of silybin on circulating adipocytokine level to explore the possible mechanism by which silybin improves high fat diet-induced obesity and diabetes. The silybin supplement significantly reduced the level of adipocytokine, such as leptin, resistin, IL-6, and MCP-1 induced by high fat diet. These results suggest that silybin can be used to improve obesity and diabetes.
Keywords
silybin; anti-obesity; high fat diet; glucose intolerance; adipocytokine;
Citations & Related Records
연도 인용수 순위
  • Reference
1 http://en.wikipedia.org/wiki/Silibinin
2 Ka, S. O., K. A. Kim, K. B. Kwon, J. W. Park, and B. H. Park (2009) Silibinin attenuates adipogenesis in 3T3-L1 preadipocytes through a potential upregulation of the insig pathway. Int. J. Mol. Med. 23: 633-7.
3 Abete, I., A. Astrup, J. A. Martinez, I. Thorsdottir, and M. A. Zulet (2010) Obesity and the metabolic syndrome: role of different dietary macronutrient distribution patterns and specific nutritional components on weight loss and maintenance. Nutr. Rev. 68: 214-31.   DOI   ScienceOn
4 Mathieu, P., I. Lemieux, and J. P. Despres (2010) Obesity, inflammation, and cardiovascular risk. Clin. Pharmacol. Ther. 87: 407-16.   DOI   ScienceOn
5 Krecman, V., N. Skottova, D. Walterova, J. Ulrichova, and V. Simanek (1998) Silymarin inhibits the development of diet-induced hypercholesterolemia in rats. Planta Med. 64: 138-42.   DOI
6 Kobalava, Z. D., S. V. Villevalde, and K. V. Isikova (2009) The role of adiponectin in development and progression of cardiovascular diseases. Kardiologiia 49:51-8.
7 Guzik, T. J., D. Mangalat, and R. Korbut (2006) Adipocytokines-novel link between inflammation and vascular function?. J. Physiol. Pharmacol. 57: 505-28.
8 Stofkova A. (2009) Leptin and adiponectin: from energy and metabolic dysbalance to inflammation and autoimmunity. Endocr. Regul. 43: 157-68.
9 Cheung, C. W., N. Gibbons, D. W. Johnson, and D. L. Nicol (2010) Silibinin, a promising new treatment for cancer. Anticancer Agents Med. Chem. 10: 186-95.   DOI   ScienceOn
10 Gazak, R., D. Walterova, and V. Kren (2007) Silybin and silymarin-new and emerging applications in medicine. Curr. Med. Chem. 14: 315-38.   DOI   ScienceOn
11 Flora, K., M. Hahn, H. Rosen, and K. Benner (1998) Milk thistle (Silybum marianum) for the therapy of liver disease. Am. J. Gastroenterol. 93: 139-43.   DOI   ScienceOn